Glucophage Generics Enter Market: Bristol Says It Will Not Sue Agency
Executive Summary
Generic versions of metformin will carry labeling that refers prescribers to Bristol-Myers Squibb's Glucophage label for information on pediatric patients
You may also be interested in...
AstraZeneca Sues FDA On Crestor Generics: Fighting A 'Foregone Conclusion'?
Company is waging the same legal battle Otsuka lost last year, arguing pediatric orphan indication should block approvals of ANDAs.
Ivax Glucophage XR Launch Halted By Purepac Exclusivity Suit
Purepac's lawsuit over FDA's 180-day exclusivity determination on generic metformin extended-release challenges the agency's interpretation of first-to-file rights for amended ANDAs
Ivax Glucophage XR Launch Halted By Purepac Exclusivity Suit
Purepac's lawsuit over FDA's 180-day exclusivity determination on generic metformin extended-release challenges the agency's interpretation of first-to-file rights for amended ANDAs